{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:39:28Z","timestamp":1783042768065,"version":"3.54.6"},"reference-count":33,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.5551\/jat.43299","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T22:26:33Z","timestamp":1520375193000},"page":"1032-1043","source":"Crossref","is-referenced-by-count":27,"title":["Circulating Oxidized Low-Density Lipoprotein Levels Independently Predict 10-Year Progression of Subclinical Carotid Atherosclerosis: A Community-Based Cohort Study"],"prefix":"10.5551","volume":"25","author":[{"given":"Shen","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing Municipal Key Laboratory of Clinical Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Jurgens G, Hoff HF, Chisolm GM 3rd and Esterbauer H: Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications. Chem Phys Lipids, 1987; 45: 315-336","DOI":"10.1016\/0009-3084(87)90070-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Yoshimoto R, Fujita Y, Kakino A, Iwamoto S, Takaya T and Sawamura T: The discovery of LOX-1, its ligands and clinical significance. Cardiovasc Drugs Ther, 2011; 25: 379-391","DOI":"10.1007\/s10557-011-6324-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Chen M, Kakutani M, Naruko T, Ueda M, Narumiya S, Masaki T and Sawamura T: Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun, 2001; 282: 153-158","DOI":"10.1006\/bbrc.2001.4516"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Gao S, Zhao D, Wang M, Zhao F, Han X, Qi Y and Liu J: Association Between Circulating Oxidized LDL and Atherosclerotic Cardiovascular Disease: A Meta-analysis of Observational Studies. Can J Cardiol, 2017; 33: 1624-1632","DOI":"10.1016\/j.cjca.2017.07.015"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Gomez M, Vila J, Elosua R, Molina L, Bruguera J, Sala J, Masia R, Covas MI, Marrugat J and Fito M: Relationship of lipid oxidation with subclinical atherosclerosis and 10-year coronary events in general population. Atherosclerosis, 2014; 232: 134-140","DOI":"10.1016\/j.atherosclerosis.2013.10.026"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Tsimikas S, Kiechl S, Willeit J, Mayr M, Miller ER, Kronenberg F, Xu Q, Bergmark C, Weger S, Oberhollenzer F and Witztum JL: Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study. J Am Coll Cardiol, 2006; 47: 2219-2228","DOI":"10.1016\/j.jacc.2006.03.001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Liu J, Wang W, Qi Y, Yong Q, Zhou G, Wang M, Sun J, Liu J, Jia Z and Zhao D: Association between the lipoprotein-associated phospholipase A2 activity and the progression of subclinical atherosclerosis. J Atheroscler Thromb, 2014; 21: 532-542","DOI":"10.5551\/jat.20941"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Xie W, Liu J, Wang W, Wang M, Qi Y, Zhao F, Sun J, Liu J, Li Y and Zhao D: Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDL-C: A cohort study. Int J Cardiol, 2016; 215: 293-298","DOI":"10.1016\/j.ijcard.2016.04.103"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Keil U and Kuulasmaa K: WHO MONICA Project: risk factors. Int J Epidemiol, 1989; 18: S46-55","DOI":"10.1093\/ije\/18.3_Supplement_1.S46"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ and the National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003; 289: 2560-2572","DOI":"10.1001\/jama.289.19.2560"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 2003; 26 Suppl 1: S5-20","DOI":"10.2337\/diacare.26.2007.S5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Liu J, Grundy SM, Wang W, Smith SC Jr., Vega GL, Wu Z, Zeng Z, Wang W and Zhao D: Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome. Am Heart J, 2007; 153: 552-558","DOI":"10.1016\/j.ahj.2007.01.003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Qi Y, Fan J, Liu J, Wang W, Wang M, Sun J, Liu J, Xie W, Zhao F, Li Y and Zhao D: Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study. J Am Coll Cardiol, 2015; 65: 355-363","DOI":"10.1016\/j.jacc.2014.11.019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Hernandez Hernandez R, Jaff M, Kownator S, Naqvi T, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E and Woo KS: Mannheim carotid intimamedia thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis, 2012; 34: 290-296","DOI":"10.1159\/000343145"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Van Der Meer IM, De Maat MP, Hak AE, Kiliaan AJ, Del Sol AI, Van Der Kuip DA, Nijhuis RL, Hofman A and Witteman JC: C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study. Stroke, 2002; 33: 2750-2755","DOI":"10.1161\/01.STR.0000044168.00485.02"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Huang LC, Lin RT, Chen CF, Chen CH, Juo SH and Lin HF: Predictors of Carotid Intima-Media Thickness and Plaque Progression in a Chinese Population. J Atheroscler Thromb, 2016; 23: 940-949","DOI":"10.5551\/jat.32177"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Nezu T, Hosomi N, Aoki S and Matsumoto M: Carotid Intima-Media Thickness for Atherosclerosis. J Atheroscler Thromb, 2016; 23: 18-31","DOI":"10.5551\/jat.31989"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Hunt KJ, Baker N, Cleary P, Backlund JY, Lyons T, Jenkins A, Virella G, Lopes-Virella MF and DCCT\/EDIC Research Group: Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes. Atherosclerosis, 2013; 231: 315-322","DOI":"10.1016\/j.atherosclerosis.2013.09.027"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Lopes-Virella MF, Hunt KJ, Baker NL, Lachin J, Nathan DM, Virella G, and DCCT\/EDIC Research Group: Levels of oxidized LDL and advanced glycation end productsmodified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes. Diabetes, 2011; 60: 582-589","DOI":"10.2337\/db10-0915"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R and Baigent C: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet, 2012; 380: 581-590","DOI":"10.1016\/S0140-6736(12)60367-5"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC and Stalenhoef AF: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb, 1991; 11: 298-306","DOI":"10.1161\/01.ATV.11.2.298"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL and Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A, 1984; 81: 3883-3887","DOI":"10.1073\/pnas.81.12.3883"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24) Pothineni NVK, Karathanasis SK, Ding Z, Arulandu A, Varughese KI and Mehta JL: LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation. J Am Coll Cardiol, 2017; 69: 2759-2768","DOI":"10.1016\/j.jacc.2017.04.010"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25) Sugiyama D, Higashiyama A, Wakabayashi I, Kubota Y, Adachi Y, Hayashibe A, Kawamura K, Kuwabara K, Nishimura K, Kadota A, Nishida Y, Hirata T, Imano H, Miyamatsu N, Miyamoto Y, Sawamura T and Okamura T: The Relationship between Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B and the Cardio-Ankle Vascular Index in Healthy Community Inhabitants: The KOBE Study. J Atheroscler Thromb, 2015; 22: 499-508","DOI":"10.5551\/jat.26450"},{"key":"25","doi-asserted-by":"crossref","unstructured":"26) Myung SK, Ju W, Cho B, Oh SW, Park SM, Koo BK and Park BJ: Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ, 2013; 346: f10","DOI":"10.1136\/bmj.f10"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27) Steinberg D and Witztum JL: Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation, 2002; 105: 2107-2111","DOI":"10.1161\/01.CIR.0000014762.06201.06"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28) Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE and Gaziano JM: Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA, 2012; 308: 1751-1760","DOI":"10.1001\/jama.2012.14805"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29) Sugimoto K, Ishibashi T, Sawamura T, Inoue N, Kamioka M, Uekita H, Ohkawara H, Sakamoto T, Sakamoto N, Okamoto Y, Takuwa Y, Kakino A, Fujita Y, Tanaka T, Teramoto T, Maruyama Y and Takeishi Y: LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells. Cardiovasc Res, 2009; 84: 127-136","DOI":"10.1093\/cvr\/cvp177"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30) Ding Z, Wang X, Khaidakov M, Liu S and Mehta JL: MicroRNA hsa-let-7g targets lectin-like oxidized low-density lipoprotein receptor-1 expression and inhibits apoptosis in human smooth muscle cells. Exp Biol Med (Maywood), 2012; 237: 1093-1100","DOI":"10.1258\/ebm.2012.012082"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31) Takedatsu H, Mitsuyama K, Mochizuki S, Kobayashi T, Sakurai K, Takeda H, Fujiyama Y, Koyama Y, Nishihira J and Sata M: A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease. Mol Ther, 2012; 20: 1234-1241","DOI":"10.1038\/mt.2012.24"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32) Li D, Liu L, Chen H, Sawamura T, Ranganathan S and Mehta JL: LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation, 2003; 107: 612-617","DOI":"10.1161\/01.CIR.0000047276.52039.FB"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33) Poulsen CB, Al-Mashhadi AL, von Wachenfeldt K, Bentzon JF, Nielsen LB, Al-Mashhadi RH, Thygesen J, Tolbod L, Larsen JR, Frokiaer J, Tawakol A, Vucic E, Fredrickson J, Baruch A, Frendeus B, Robertson AK, Moestrup SK, Drouet L and Falk E: Treatment with a human recombinant monoclonal IgG antibody against oxidized LDL in atherosclerosis-prone pigs reduces cathepsin S in coronary lesions. Int J Cardiol, 2016; 215: 506-515","DOI":"10.1016\/j.ijcard.2016.03.222"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34) Kayo S, Ohsawa M, Ehara S, Naruko T, Ikura Y, Hai E, Yoshimi N, Shirai N, Tsukamoto Y, Itabe H, Higuchi K, Arakawa T and Ueda M: Oxidized low-density lipoprotein levels circulating in plasma and deposited in the tissues: comparison between Helicobacter pylori-associated gastritis and acute myocardial infarction. Am Heart J, 2004; 148: 818-825","DOI":"10.1016\/j.ahj.2004.05.042"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/25\/10\/25_43299\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T04:42:55Z","timestamp":1538800975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/25\/10\/25_43299\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.43299","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}